NEW YORK (GenomeWeb News) - Fluidigm said last week that the Department of Chemical Pathology at the Chinese University of Hong Kong has licensed its BioMark real-time PCR system.
Fluidigm said that the lab is using the system to study viruses associated with cancer, to detect somatic mutations in genes, and to develop gene expression profiles, among other molecular diagnostic research projects.
Financial terms of the agreement were not provided.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.